Completed KT-621 (STAT6) SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed...
results
Operating revenues of $5.196 billion for the first quarter of 2025, 1% lower year over year. Operating loss of $108...
Reports First-Quarter Diluted EPS of $0.72 on a GAAP Basis, a Decrease of 6.5 Percent; Adjusted Diluted EPS of $2.46,...
Today, GE Vernova released its first quarter 2025 financial results. We had a strong start to 2025 with continued growth,...
CAPE CANAVERAL, Fla., March 31, 2025--(BUSINESS WIRE)--Sidus Space (NASDAQ: SIDU) (the "Company" or "Sidus"), an innovative, agile space mission enabler,...
Continues to Make Progress on "iRobot Elevate" Strategy Board of Directors Initiates Review of Strategic Alternatives BEDFORD, Mass., March 12,...
